Vimarsana
Biggest News Aggregation in the World

Sisonke Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sisonke Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sisonke Study Today - Breaking & Trending Today

Claims and counterclaims on Covid-19 'conspiracy' - Vimarsana News

Claims and counterclaims on Covid-19 'conspiracy'

Once more we find Karim’s presence and influence in these organisations that led our understanding of Covid-19 and the official response.

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial - Vimarsana News

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

Saimbarashe Takuva, Azwi Takalani, and colleagues investigate the frequency and incidence of adverse events reported after receipt of a single dose of the Ad26.COV2.S COVID-19 vaccine among health care workers in South Africa.

Source: plos.org
SA medical scientists to evaluate efficacy of Moderna COVID jab as booster shot - Vimarsana News

SA medical scientists to evaluate efficacy of Moderna COVID jab as booster shot

The Sisonke study team is launching the Sherpa Study that will assess the Moderna booster in protecting against COVID-19 infections and severe COVID-19 disease among healthcare workers.

Source: ewn.co.za
Second J&J shot prevents hospitalisation, severe Covid-19 - study - Vimarsana News

Second J&J shot prevents hospitalisation, severe Covid-19 - study

A new study shows that people who receive a second dose of the Johnson & Johnson Covid-19 vaccine are less likely to end up in hospital for the disease.

Source: news24.com
Second J&J shot prevents hospitalisation, severe Covid-19 – study - Vimarsana News

Second J&J shot prevents hospitalisation, severe Covid-19 – study

A new study shows that people who receive a second dose of the Johnson & Johnson (J&J) Covid-19 vaccine are less likely to end up in hospital for the disease.   The study, published in the New England Journal of Medicine by the Sisonke Study team, is one of the first real-world studies on vaccine effectiveness against the Omicron variant of the virus that causes Covid-19.